• Metabolic Control of TBK1: Itaconic Acid Restrains IFN-I Sig

  2026-05-09

  Chai et al. (2025) uncover a metabolic feedback loop in which IRG1-catalyzed itaconic acid alkylates TBK1, directly inhibiting its dimerization and suppressing overactive type I interferon responses. These findings elucidate a novel mechanism linking cellular metabolism to immune regulation and suggest new avenues for targeted intervention in hyperinflammatory conditions.

• Resiniferatoxin (RTX): Targeted TRPV1 Inactivation for Osteo

  2026-05-09

  Explore the unique mechanism and clinical promise of Resiniferatoxin (RTX) as an ultra-potent, selective TRPV1 agonist for osteoarthritis pain relief. This article delivers a deep-dive into RTX's chemical inactivation of sensory neurons, protocol nuances, and translational significance for pain research.

• FPH1 (BRD-6125): Advancing Human Hepatocyte Proliferation As

  2026-05-08

  FPH1 (BRD-6125) enables reproducible expansion of functional primary human hepatocytes, independent of donor genetic background. Its robust performance in albumin secretion and CYP3A4 activity makes it a critical tool for drug discovery, iPS cell differentiation, and regenerative medicine workflows.

• Estradiol (A8425): Deep Mechanistic Insights for Multi-Organ

  2026-05-07

  Explore the multifaceted role of estradiol in organ protection and metabolic regulation. This article uniquely connects estrogen receptor signaling with autophagy, providing advanced scientific analysis and protocol parameters for researchers investigating 17 beta-estradiol.

• ECL Chemiluminescent Substrate Detection Kit: Sensitivity &

  2026-05-07

  The ECL Chemiluminescent Substrate Detection Kit (Hypersensitive) enables ultra-sensitive immunoblotting detection via horseradish peroxidase (HRP) chemiluminescence. This kit consistently detects low-abundance proteins at picogram levels with minimal background and extended signal stability, offering robust performance for Western blot applications.

• Optimized hiPSC Platelet Differentiation: Protocol Advances

  2026-05-06

  This study presents an optimized protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs), addressing cost, efficiency, and functional limitations. Key advancements include substitution of cytokines with small molecules and enhancement of megakaryocyte maturation, enabling a 58.3% reduction in production costs and increased platelet yield.

• NU7441 (KU-57788): Precision DNA-PK Inhibition in Oncology R

  2026-05-06

  NU7441 (KU-57788) empowers next-generation DNA repair and immunity studies by enabling selective, nanomolar inhibition of DNA-PK. Its robust specificity and translational workflow compatibility make it essential for dissecting DNA damage responses and optimizing cancer therapeutics.

• CHI3L1-IN-5 (Compound Z17): Applied Workflows for Neuroinfla

  2026-05-05

  CHI3L1-IN-5 (Compound Z17) stands out as a highly selective CHI3L1 inhibitor, enabling precise modulation of neuroinflammatory signaling and restoration of astrocyte function. This article details evidence-driven protocols, troubleshooting strategies, and practical enhancements to accelerate Alzheimer's disease research with APExBIO's advanced compound.

• Iptacopan (LNP023): Mechanistic Insight and Translational Im

  2026-05-05

  Explore the scientific foundation and translational significance of Iptacopan (LNP023), a highly selective oral complement factor B inhibitor. This article uniquely deciphers its mechanism, assay choices, and clinical relevance—providing context beyond current protocol-focused content.

• HotStart™ 2X Green qPCR Master Mix: Technical Guide & Workfl

  2026-05-04

  HotStart™ 2X Green qPCR Master Mix addresses non-specific amplification and primer-dimer formation in real-time PCR gene expression analysis, nucleic acid quantification, and RNA-seq validation. It is best suited for applications requiring SYBR Green-based detection and hot-start Taq polymerase inhibition. This product is not designed for probe-based qPCR or applications outside real-time PCR workflows.

• Chlorpromazine Workflows: Applied Protocols for Antipsychoti

  2026-05-04

  Chlorpromazine hydrochloride enables precise modeling of dopaminergic and antiemetic pathways in translational neuropharmacology. This guide delivers actionable workflows, advanced troubleshooting, and protocol enhancements tailored to maximize reproducibility and data quality when leveraging APExBIO’s high-purity chlorpromazine for antipsychotic and hepatic interaction studies.

• Adipose-Neural Axis and Arrhythmia: Mechanisms from Cocultur

  2026-05-03

  Fan et al. (2024) present compelling evidence that the adipose-neural axis, mediated by leptin and neuropeptide Y signaling, contributes to the pathogenesis of epicardial adipose tissue (EAT)-related cardiac arrhythmias. Their stem cell-based coculture model elucidates actionable molecular targets and offers a robust experimental platform to dissect neuro-cardiac interactions, informing both mechanistic understanding and future therapeutic strategies.

• Chlorpromazine Hydrochloride: Strategic Insights for Transla

  2026-05-02

  This thought-leadership article explores the mechanistic versatility and translational impact of chlorpromazine, with a special focus on its role as a dopamine D2 receptor antagonist in both CNS and hepatic nanoparticle research. We synthesize recent evidence on hepatic microenvironment interactions, strategic protocol parameters, and workflow advancements, distinguishing our approach from conventional product summaries. The narrative bridges neuropharmacology and nanomedicine, providing actionable guidance for translational researchers seeking to harness APExBIO chlorpromazine for competitive and reproducible outcomes.

• Phosphatase Inhibitor Cocktail 2: Safeguarding Proteostasis

  2026-05-02

  Explore how Phosphatase Inhibitor Cocktail 2 enables advanced protein phosphorylation preservation for neurodegeneration and aging studies. This article uniquely bridges inhibitor selection with insights from SIRT6-regulated proteostasis, offering deep guidance for experimental design.

• (-)-Norepinephrine (+)-bitartrate in Experimental Blood Pres

  2026-05-01

  Explore the nuanced role of (-)-Norepinephrine (+)-bitartrate in blood pressure regulation research. This article uniquely analyzes dosing equivalence, translational modeling, and protocol design, offering deep guidance for cardiovascular investigators.

454 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page